Direct answerthe US is the largest Nutra market because the consumer has high purchasing power and the average order value sits around USD 300 per sale. To earn there, the challenge is not just traffic, it is payments: approving the American card (a rate above 80% is already good for international sales), controlling the aggressive chargeback behavior of the US buyer (a maximum limit of 0.90% of volume), and presenting a checkout in dollars and in English. FDA compliance is mandatory, but it is a regulatory matter, covered in its own article. On the financial side, the gateway is what solves approval, chargeback prevention, and localized checkout.

Why is the US the largest Nutra market?

Nutra is short for nutraceutical: dietary supplements sold online, usually promising weight loss, energy, longevity, or performance. And the consumer who buys the most of this kind of product is in the United States.

The explanation has two parts. The first is cultural: supplementation is part of the American's daily life in a way that does not happen in most countries. The second is financial: purchasing power is high, and the average order value of a Nutra sale sits around USD 300, well above a typical digital product, which is closer to USD 20.

Add the two together and you understand why this is the category with the highest LTV and lowest churn in Mundpay's base. The American Nutra buyer is worth a lot per sale and tends to repeat. The problem is that this same buyer comes wrapped in three payment challenges that almost nobody anticipates. That is what the rest of this article covers. For the complete picture of the operation, the international payments guide for Nutra brings it all together in one place.

Why does the American card decline, and how do you approve more?

The first obstacle appears before any sale even lands: approval. When a seller sells into the US, the American issuing bank sees a transaction coming from another country, in a category with a fraud history, and grows suspicious. The result is a decline.

To put it in scale: for international sales, an approval rate above 80% is already considered good. What pulls that number down is the geographic distance between seller and buyer, the card brand, and the business model itself. Nutra carries all of these signals at once.

The tool that recovers these sales is smart retry. When a card is declined, instead of showing "payment declined" and losing the buyer, the system automatically routes the transaction to alternative acquirers and banks within fractions of a second. The buyer does not even notice: they do not re-enter their details, they see no error, the purchase simply goes through. Every recovered decline on a USD 300 order is money that was already about to walk away.

Chargebacks in the US: why are they aggressive, and how do you prevent them?

If approval is the obstacle on the way in, chargeback is the one on the way out. American consumers contact their bank to dispute a charge with an ease that unsettles anyone used to the Brazilian market. A chargeback is a forced reversal: the buyer goes straight to the bank, without talking to the seller, and the money comes back.

The cost is twofold. At Mundpay, each chargeback costs a fixed BRL 60.00 plus the refund of the gross amount of the sale. And there is a ceiling: the maximum limit tolerated by acquirers is 0.90% of transacted volume. Blowing past that puts the entire operation at risk of being blocked. The full numbers are on the payments and fees page.

The good news is that chargebacks can be prevented before they happen. The mechanism is the pre-chargeback: an alert the banking system issues before the reversal becomes formal. At Mundpay it costs BRL 80.00 per alert and opens a window to resolve the dispute preventively, through a refund or by contacting the buyer. About 90% of these alerts are resolved before turning into a chargeback. Add to that the proactive risk team, which contacts the seller before applying any restriction, and you have a layer of defense that most platforms do not offer. The prevention logic applied to sales outside Brazil is detailed in the article on fraud prevention for international digital products.

What about FDA compliance?

Some honesty is due here: payments and regulation are different things, and mixing them causes confusion. This article is about the financial side. But ignoring the FDA would be irresponsible, so here is the summary.

Dietary supplements do not go through prior FDA approval the way a drug does. There is no "approved" seal you wait for before selling. What exists are labeling rules, health claims rules, and good manufacturing practices the seller needs to follow. The most common trigger for trouble is the exaggerated claim: promising a cure, a guaranteed result, or a medical benefit the product does not deliver. That does not just attract the regulator, it attracts the dissatisfied buyer who disputes the purchase, which throws you right back into the chargeback problem from the previous section.

Because the topic is extensive and has rules of its own, it is covered in detail in the dedicated article on FDA regulations for Nutra sellers. Read it before you scale. On the payments side, let's continue.

Users spend most of their time on other sites. This means that users prefer your site to work the same way as all the other sites they already know.

Jakob Nielsen Source: Nielsen Norman Group.

What should the checkout look like for the American buyer?

You have solved approval and shielded the chargeback rate. What is left is the piece the buyer actually sees: the checkout. And nothing scares off an American buyer faster than a payment page in Brazilian reals and Portuguese.

The US buyer expects three things: price in dollars, page in English, and a flow that feels local, not imported. When the checkout shows "R$" or asks for details in another language, the immediate read is "this is not for me" or, worse, "this is a scam." Abandonment goes up and approval drops right along with it, because the bank also reads friction as risk.

Mundpay solves this automatically: it identifies the buyer's language and currency by IP and converts BRL, USD, and EUR into the local currency, across 190 countries. For the US, the buyer sees the page in English, the price in dollars, and checks out without feeling like they crossed a border. The detail of why local currency changes the conversion is covered in the article on local currency conversion at checkout.

What is the gateway's role in selling Nutra to the US?

Notice that the three financial challenges of selling Nutra in the US (approving the card, containing chargebacks, and localizing the checkout) are not solved by the offer or by traffic. They are solved by the infrastructure that processes the payment. That is the gateway.

A common gateway approves what it can and passes the problem along. A gateway built for international sales works all three fronts at once:

  • Approval: smart retry that recovers declines without friction for the buyer.
  • Chargeback: pre-chargeback and a proactive risk team, resolving about 90% of alerts before they become a reversal.
  • Checkout: automatic language and currency translation by IP, so the American buyer sees dollars and English.

On a USD 300 order, each of these fronts carries real financial weight. Recovering a declined sale, avoiding a chargeback, or not losing the buyer at checkout is each worth hundreds of dollars. That is why, in Nutra for the US, choosing the gateway is not a technical detail. It is the decision that separates an operation that generates revenue from one that bleeds it out at every invisible step.

In short: selling Nutra in the US

  • The US is the largest Nutra market thanks to high purchasing power and an average order value of about USD 300 per sale, the category with the highest LTV and lowest churn.
  • The American card declines international sales easily; above 80% approval is already good, and smart retry recovers declines without the buyer re-entering data.
  • Chargebacks are aggressive in the US: they cost a fixed BRL 60.00 plus the gross amount, with a limit of 0.90% of volume, prevented with pre-chargeback and proactive risk (about 90% of alerts resolved beforehand).
  • The FDA does not pre-approve supplements, but it requires correct labeling and claims; the regulatory topic is covered in a dedicated article.
  • The checkout needs to show the price in dollars and the page in English; Mundpay translates language and currency by IP across 190 countries.
  • Approval, chargeback prevention, and localized checkout are solved by the gateway, not by the offer or the traffic.

FAQ: Frequently asked questions on selling Nutra to the US

Why is the US the biggest Nutra market?

Because the American consumer has high buying power and a settled culture of supplementation. Average Nutra sale ticket runs around USD 300, well above typical digital products. In Mundpay's base, Nutra is the category with the highest lifetime value and lowest churn, making the US buyer the most valuable per transaction. The tradeoff is the market demands high card approval, strict chargeback management, and FDA compliance.

Why do American cards decline Nutra sales so often?

Declines come from geographic distance between seller and buyer, the category's fraud history, and the risk reading from card issuers. For international sales, approval above 80% is already considered good. Mundpay raises that number with smart retry, which automatically reroutes a declined transaction to alternate processors and banks in fractions of a second, no need for the buyer to re-enter card data.

How do chargebacks work in Nutra sales to the US?

The American buyer calls their bank readily to contest charges, making chargebacks aggressive in Nutra. At Mundpay each chargeback costs R$ 60.00 flat plus the gross amount refunded, and processors tolerate maximum 0.90% of volume. Prevention comes from pre-chargeback: an alert before formal reversal, costing R$ 80.00 and letting you resolve the dispute first. Roughly 90% of alerts resolve before becoming chargebacks.

Do you need FDA approval to sell Nutra in the US?

Dietary supplements skip pre-approval like drugs do with FDA, but the seller must follow labeling rules, health claims policies, and manufacturing practices. Claims of cure or overstated promises are the main trigger for problems, both with regulators and with buyers who dispute the purchase. This article covers the payments side. The regulatory part is detailed in a dedicated FDA compliance guide for Nutra sellers.

Must the checkout display dollars to sell Nutra to the US?

Yes. The American buyer expects to see the price in dollars and the page in their language. A checkout in real or Portuguese raises abandonment and cuts approval. Mundpay auto-shifts language and currency by the buyer's IP and converts BRL, USD, and EUR to their local money across 190 countries. For the US market that means USD price, English page, and less friction between click and purchase.

How exactly does smart retry work?

When a card gets declined by a bank or processor, smart retry doesn't show the buyer an error. Instead it reroutes the same transaction automatically to another processor or alternate bank in fractions of a second. The buyer sees nothing, doesn't re-enter data, gets no error notice. From their angle the payment just went through. Statistically a chunk of declines is artificial, not real: the origin bank declines from policy but another bank takes the same transaction. Smart retry captures those invisible wins.

Does smart retry hurt approval if it tries too many times?

No, because the retry is smart. It doesn't keep hammering the same card forever. It reroutes to different paths: different processor, different bank, different circuit. Protocols define how many tries make sense without damaging the buyer's history or triggering fraud alerts. At Mundpay the mechanism is tuned to recover sales without creating noise. The goal is silent fixing, not turning one transaction into an attack.